Biography
Natalie practices before U.S. federal courts and the U.S. Patent and Trademark Office, with a focus on pharmaceuticals, biotechnology and protein chemistry. She has extensive training and experience in a variety of life sciences areas, including monoclonal antibodies, stem cell therapies, vaccines, and other technologies at the intersection of immunology, molecular biology, biochemistry, and cell biology.
Prior to joining Weil, Natalie worked for several years as a patent agent, preparing and prosecuting U.S. and international patent applications, rendering opinions, and conducting due diligence investigations in a variety of life sciences specialties. She attended Fordham Law’s evening program and was a member of the Fordham Law Review and the Order of the Coif, while working full-time as a patent agent at a major international law firm.
Natalie is licensed to practice before the U.S. Patent and Trademark Office.
Firm News & Announcements, Speaking Engagements, Guides and Resources, Latest Thinking, Awards and Recognition
Firm News & Announcements
- Weil Aids Oceana in Campaign to Stop Shark Finning and Shark Fin Trading in the U.S. Litigation Win — January 14, 2022
Speaking Engagements
-
Life Sciences Year in Review
Speaker(s):
Edward R. Reines and
Natalie C. Kennedy
June 14, 2023 — Berkeley — Patent Litigation and Life Sciences Practice Co-Head Edward Reines and Counsel Natalie Kennedy appeared on this panel discussing recent legal developments in the Life Sciences sector over the past year as part of the Berkeley Center of Law and Technology’s IP & Tech Month 2023.